JY
LTRN icon

Jeff Yass’s Lantern Pharma LTRN Stock Holding History

Jeff Yass’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.7K Buy
+14,073
New +$41.3K ﹤0.01% 12768
2026
Q1 		– Sell
-28,820
Closed -$87.3K – 13701
2025
Q4 		$87.3K Sell
28,820
-10,274
-26% -$38.2K ﹤0.01% 11528
2025
Q3 		$170K Buy
+39,094
New +$163K ﹤0.01% 11153
2025
Q2 		– Sell
-14,949
Closed -$52.9K – 13272
2025
Q1 		$52.9K Sell
14,949
-11,352
-43% -$47.1K ﹤0.01% 11841
2024
Q4 		$83.9K Buy
26,301
+4,420
+20% +$15.1K ﹤0.01% 11446
2024
Q3 		$80.3K Sell
21,881
-37,878
-63% -$156K ﹤0.01% 11169
2024
Q2 		$279K Buy
59,759
+33,975
+132% +$204K ﹤0.01% 9617
2024
Q1 		$227K Buy
+25,784
New +$138K ﹤0.01% 10337
2023
Q3 		– Sell
-10,581
Closed -$59.7K – 12543
2023
Q2 		$59.7K Buy
+10,581
New +$54.7K ﹤0.01% 11260
2022
Q4 		– Sell
-14,558
Closed -$70K – 13144
2022
Q3 		$70K Buy
+14,558
New +$78.3K ﹤0.01% 11992
2022
Q1 		– Sell
-10,439
Closed -$83K – 13568
2021
Q4 		$83K Sell
10,439
-470
-4% -$4.29K ﹤0.01% 12262
2021
Q3 		$122K Buy
+10,909
New +$141K ﹤0.01% 11939

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Jeff Yass's LTRN Position: Q2 2026 in Review

Jeff Yass opened a new position in Lantern Pharma (LTRN) in Q2 2026: 14,073 shares worth $58.7K. The stake represents ﹤0.01% of the portfolio and ranks #12768 among its holdings. This is a return to the name: Jeff Yass previously reported a position in LTRN as recently as Q4 2025.

Jeff Yass first reported a position in LTRN in Q3 2021 and has held it in 12 quarters since. The position peaked at $279K in Q2 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Jeff Yass held 14,073 shares of Lantern Pharma worth $58.7K as of Q2 2026.
  • Lantern Pharma was a new Jeff Yass position in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12768 holding.
  • Jeff Yass first reported a position in Lantern Pharma in Q3 2021 and has held it in 12 quarters since.
  • Jeff Yass's Lantern Pharma position peaked at $279K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.